New drug cocktail IoVeX aims to tame relapsed leukemia
NCT ID NCT06863259
First seen Feb 20, 2026 · Last updated Apr 30, 2026 · Updated 10 times
Summary
This early-phase trial tests whether a combination of three drugs (inotuzumab ozogamicin, venetoclax, and dexamethasone) is safe for people whose B-cell acute lymphoblastic leukemia has returned. About 28 children and adults will receive the treatment over one or two 28-day cycles. The main goal is to identify side effects and see if the drugs are tolerable.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cincinnati Children's Hospital Medical Center
RECRUITINGCincinnati, Ohio, 45229, United States
Conditions
Explore the condition pages connected to this study.